# Aspen Neuroscience (ASPE) — News

ASPE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/aspe/news

## Recent headlines

- [Trading halted: (ASPE) Due to limit-up limit-down trading pause](https://www.ainvest.com/news/trading-halted-aspe-due-limit-limit-trading-pause-2610) — AInvest Wire, Oct 30, 2026
  Trading in shares of Aspen Neuroscience Inc (ASPE) has been temporarily suspended due to the activation of the "limit-up-limit-down" mechanism, a regulatory tool designed to curb excessive volatility in trading markets. This mechanism, approved by the U.S. Securities and Exchange Commission (SEC),…
- [Aspen Neuroscience opens at $14.70, IPO at $15](https://www.ainvest.com/news/aspen-neuroscience-opens-14-70-ipo-15-2610) — AInvest Wire, Oct 30, 2026
  Aspen Neuroscience (ASPE) made its initial public offering (IPO) on October 30, 2026, with a listing price of $15 per share. However, the stock opened at $14.70, slightly below the IPO price, reflecting early market dynamics and investor sentiment. The company, which focuses on developing cell…
- [Aspen Neuroscience shares indicated at $15; IPO price $15](https://www.ainvest.com/news/aspen-neuroscience-shares-15-ipo-price-15-2610) — AInvest Wire, Oct 30, 2026
  Aspen Neuroscience (NASDAQ: ASPE) launched its initial public offering (IPO) on October 26, 2026, with shares priced at $15 per share, aligning with the lower end of its expected range . The company is marketing 9.38 million shares as part of the offering, aiming to raise up to $155 million in…
- [Aspen Neuroscience prices IPO at $15.00/share](https://www.ainvest.com/news/aspen-neuroscience-prices-ipo-15-00-share-2610) — AInvest Wire, Oct 30, 2026
  Aspen Neuroscience (ASPE Proposed) has priced its initial public offering (IPO) at $15.00 per share, according to recent filings and market updates. The company, which is developing autologous induced pluripotent stem cell (iPSC) therapies for neurological disorders, is seeking to advance its…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).